Pathology AI “PidPort” enables highly accurate and rapid presentation of analysis results and online pathological diagnosis
| STAFF | Osamu Iizuka (CEO) |
| FOUNDED | 2018 |
| SECTOR | DeepTech, HealthTech & SportsTech, MedTech |
| BUSINESS MODEL | B2B, B2C |
| WEBSITE | https://en.medmain.com |
| CONTACT | pr-m@medmain.com |
Social Media
Product or service
PidPort enables pathology screening through its unique AI-based image processing technology, and also has a remote pathology diagnosis function. PidPort supports the medical field with AI-based pathology image analysis.
Vision
Realize a better medical environment and “create a world where people can receive the medical care they need anytime, anywhere through technology.